Sodium Bicarbonate Plus Isotonic Saline Versus Saline for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Controlled Trial

American Journal of Kidney Diseases

Volumn 54, Issue 4, 2009, Pages 610-618

  Vasheghani Farahani, Ali ^a   Sadigh, Gelareh ^a   Kassaian, Seyed Ebrahim ^a   Khatami, Seyed Mohammad Reza ^a   Fotouhi, Akbar ^b   Razavi, Seyed Amir Hossein ^a   Mansournia, Mohammad Ali ^b   Yamini Sharif, Ahmad ^a   Amirzadegan, Alireza ^a   Salarifar, Mojtaba ^a   Sadeghian, Saeed ^a   Davoodi, Gholamreza ^a   Borumand, Mohammad Ali ^a   Esfehani, Farah Aiatollahzade ^a   Darabian, Sirous ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiography; complications; contrast media; kidney; prevention

Indexed keywords

BICARBONATE; CREATININE; IODIXANOL; IOHEXOL; ISOTONIC SALT SOLUTION; MEGLUMINE DIATRIZOATE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CONTRAST MEDIUM; IODOBENZOIC ACID DERIVATIVE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; IRAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RANDOMIZED CONTROLLED TRIAL; URINE PH; ACUTE KIDNEY FAILURE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; FLUID THERAPY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; TIME; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; IOHEXOL; MALE; MIDDLE AGED; ODDS RATIO; RENAL INSUFFICIENCY, ACUTE; SODIUM BICARBONATE; SODIUM CHLORIDE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS;

EID: 70349580111     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.05.016     Document Type: Article

References (32)

1. Habeb M., Aǧaç M.T., Aliyev F., Pehlivanoǧlu S., and Ongen Z. Contrast media-induced nephropathy: Clinical burden and current attempts for prevention. Anadolu Kardiyol Derg 5 (2005) 124-129
2. McCullough P.A. Contrast-induced acute kidney injury. J Am Coll Cardiol 51 (2008) 1419-1428
3. Sanaei-Ardekani M., Movahed M.R., Movafagh S., and Ghahramani N. Contrast-induced nephropathy: A review. Cardiovasc Revasc Med 6 (2005) 82-88
4. Lin J., and Bonventre J.V. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 14 (2005) 105-110
5. Schmidt P., Pank D., Nykamp D., Knowlton G., and Jia H. N-Acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Ann Pharmacother 41 (2007) 46-50
6. Kelly A.M., Dwamena B., Cronin P., Bernstein S.J., and Carlos R.C. Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148 (2008) 284-294
7. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 291 (2004) 2328-2334
8. Ozcan E.E., Guneri S., Akdeniz B., et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 154 (2007) 539-544
9. Maioli M., Toso A., Leoncini M., et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52 (2008) 599-604
10. From A.M., Bartholmai B.J., Williams A.W., Cha S.S., Pflueger A., and McDonald F.S. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic. Clin J Am Soc Nephrol 3 (2008) 10-18
11. Pannu N., Wiebe N., and Tonelli M.f.t.A.K.D.N. Prophylaxis strategies for contrast-induced nephropathy. JAMA 295 (2006) 2765-2779
12. Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
13. Erley C.M. Kontrastmittel-induzierte nephropathie. Intensivmed 42 (2005) 39-46
14. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
15. Marenzi G., and Bartorelli A.L. Recent advances in the prevention of radiocontrast-induced nephropathy. Curr Opin Crit Care 10 (2004) 505-509
16. Barreto R. Prevention of contrast-induced nephropathy: The rational use of sodium bicarbonate. Nephrol Nurs J 34 (2007) 417-421
17. Asif A., Garces G., Preston R.A., and Roth D. Current trials of interventions to prevent radiocontrast-induced nephropathy. Am J Ther 12 (2005) 127-132
18. Assadi F. Acetazolamide for prevention of contrast-induced nephropathy: A new use for an old drug. Pediatr Cardiol 27 (2006) 238-242
19. Maeder M., Klein M., Fehr T., and Rickli H. Contrast nephropathy: Review focusing on prevention. J Am Coll Cardiol 44 (2004) 1763-1771
20. Cavusoglu E., Chhabra S., Marmur J.D., Kini A., and Sharma S.K. The prevention of contrast-induced nephropathy in patients undergoing percutaneus coronary intervention. Minerva Cardioangiol 52 (2004) 419-432
21. Morcos S.K. Prevention of contrast media-induced nephrotoxicity after angiographic procedures. J Vasc Interv Radiol 16 (2005) 13-23
22. Iyisoy A., Celik T., Yuksel U.C., Bugan B., and Isik E. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: A potentially catastrophic complication of the percutaneous coronary interventions. Int J Cardiol 134 (2009) 431-433
23. Briguori C., Airoldi F., D'Andrea D., et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 115 (2007) 1211-1217
24. Masuda M., Yamada T., Mine T., et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 100 (2007) 781-786
25. Recio-Mayoral A., Chaparro M., Prado B., et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO Study. J Am Coll Cardiol 49 (2007) 1283-1288
26. Brar S.S., Shen A.Y., Jorgensen M.B., et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. JAMA 300 (2008) 1038-1046
27. Fauci A.S., Braunwald E., Kasper D.L., et al. Harrison's Principles of Internal Medicine. ed 17 (2008), Mc Graw Hill, New York, NY 260-270
28. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
29. Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
30. Montori V.M., Devereaux P.J., Adhikari N.K., et al. Randomized trials stopped early for benefit. JAMA 294 (2005) 2203-2209
31. Guyton A.C., and Hall J.E. Textbook of Medical Physiology. ed 10 (2000), Saunders, Philadelphia, PA 300-303
32. Merten G.J., Burgess W.P., Rittase R.A., and Kennedy T.P. Prevention of contrast-induced nephropathy with sodium bicarbonate: An evidence-based protocol. Crit Pathw Cardiol 3 (2004) 138-143